Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers

American Journal of Industrial Medicine

Volumn 32, Issue 1, 1997, Pages 15-20

  Sithisarankul, Pornchai ^a   Schwartz, Brian S ^a   Lee, Byung Kook ^b   Kelsey, Karl T ^c   Strickland, Paul T ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Soonchunhyang University   (South Korea)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

aminolevulinic acid; blood lead; genotype; lead exposed workers; neurotoxin

Indexed keywords

AMINOLEVULINIC ACID; LEAD; NEUROTOXIN; PORPHOBILINOGEN SYNTHASE;

ADULT; ARTICLE; GENOTYPE; HEME SYNTHESIS; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; NEUROTOXICITY; OCCUPATIONAL EXPOSURE;

ADULT; AMINOLEVULINIC ACID; GENOTYPE; HUMANS; KOREA; LEAD; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PORPHOBILINOGEN SYNTHASE;

EID: 0030924965     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q     Document Type: Article

References (48)

1. Audesirk G (1985): Effects of lead exposure on the physiology of neurons. Prog Neurobiol 24:199-231.
2. Astrin KH, Bishop DF, Wetmur JG, Kaul B, Davidow B, Desnick RJ (1987): δ-Amino-levulinic acid dehydratase isozymes and lead toxicity. Ann NY Acad Sci 514:23-29.
3. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S (1981): Delta-aminolevulinate dehydrase: A new genetic polymorphism in man. Ann Hum Genet 45:223-229.
4. Becker DM, Goldstuck N, Kramer S (1975): Effect of delta-aminolaevulinic acid on the resting membrane potential of frog sartorius muscle. S Afr Med J 49:1790-1792.
5. Bellinger D, Hu H, Titlebaum L, Needleman HL (1994): Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 49:98-105.
6. Benkmann HG, Bogdanski P, Goedde HW (1983): Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered 33:62-64.
7. Bloomer JR, Bonkovsky HL (1989): The porphyrias. Disease-a-Month 35:1-54.
8. Bonkowsky HL, Schady W (1982): Neurologic manifestations of acute porphyria. Sem Liver Dis 2:108-124.
9. Brennan MJW, Cantrill RC (1979): δ-Aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature 280:514-515.
10. Brennan MJW, Cantrill RC (1981): Delta-aminolevulinic acid and amino-acid neurotransmitters. Mol Cell Biochem 38:49-58.
11. Brennan MJW, Cantrill RC, Kramer S (1980): Effect of δ-aminolaevulinic acid on GABA receptor binding in synaptic plasma membranes. Int J Biochem 12:833-835.
12. Burtis CA, Ashwood ER (1994): "Teitz Textbook of Clinical Chemistry." WB Saunders: Philadelphia, pp 1221-1222, 2020-2021, 2096-2097.
13. Cutler MG, McLaughlin M, McNeil E, Moore MR (1985): Effects of delta-aminolaevulinic acid on contractile activity in the isolated small intestine of the rabbit. Neuropharmacol 24:1005-1009.
14. Doss M, von Tiepermann R, Schneider J, Schmid H (1979): New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochens 57:1123-1127.
15. Doss M, Becker U, Sixel F, Geisse S, Solcher H, Schneider J, Kufner G, Schlegel H, Stoeppler M. (1982): Persistent protoporphyrinemia in hereditary porphobilinogen synthase (δ-aminolevulinic acid dehydratase) deficiency under low lead exposure. Klin Wochens 60:599-606.
16. Doss M, Laubenthal F, Stoeppler M (1984): Lead poisoning in inherited δ-aminolevulinic acid dehydratase deficiency. Int Arch Occup Environ Health 54:55-63.
17. Gorchein A, Webber R (1987): δ-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: Studies in normal, uraemic and porphyric subjects. Clin Sci 72:103-112.
18. Hassoun A, Verstraeten L, Mercelis R, Martin JJ (1989): Biochemical diagnosis of an hereditary aminolaevulinate dehydratase deficiency in a 63-year-old man. J Clin Chem Clin Biochem 27:781-786.
19. Hosoda K, Sakurai H, Omae K, Kamakura M, Satoh T (1989): δ-Aminolevulinic acid in blood as an indicator of early health effect of lead. Sangyo Igaku 31:240-241 (in Japanese).
20. Kappas A, Sassa S, Galbraith RA, Nordmann Y (1995): The porphyrias. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) "The Metabolic and Molecular Bases of Inherited Disease (7th edition)." McGraw-Hill: New York, pp 2103-2159.
21. McGillion FB, Moore MR, Goldberg A (1973): The effect of δ-aminolaevulinic acid on the spontaneous activity of mice. Scot Med J 18:133.
22. McGillion FB, Thompson GG, Moore MR, Goldberg A (1974): The passage of δ-aminolaevulinic acid across the blood-brain barrier of the rat: Effect of ethanol. Biochem Pharmacol 23:472-474.
23. Minder EI (1986): Measurement of 5-aminolevulinic acid by reversed phase HPLC and fluorescence detection. Clin Chim Acta 161:11-18.
24. Minnema DJ, Michaelson IA (1986): Differential effects of inorganic lead and delta-aminolevulinic acid in vitro on synaptosomal gamma-aminobutyric acid release. Toxicol Appl Pharmacol 86:437-447.
25. Miyajima K, Hirata M, Yoshida T, Kosaka H, Okayama A (1994): Study on measurement of δ-aminolevulinic acid in plasma by high-performance liquid chromatography. J Chromat B 654:165-169.
26. Morita Y, Araki S, Sakai T, Araki T, Masuyama Y (1994): Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: A sensitive indicator of lead effects. Ind Health 32:85-96.
27. Morita Y, Sakai T, Araki S, Araki T, Masuyama Y (1993): Usefulness of δ-aminolevulinic acid in blood as an indicator of lead exposure. Sangyo Igaku 35:112-118 (in Japanese).
28. Muller WE, Snyder SH (1977): δ-Aminolevulinic acid: Influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol 2:340-342.
29. Nicoll RA (1976): The interaction of porphyrin precursors with GABA receptors in the isolated frog spinal cord. Life Sci 19:521-526.
30. Percy VA, Shanley BC (1970): Porphyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria. S Afr Med J 52:219-222.
31. Plewinska M, Thunell S, Holmberg L, Wetmur JG, Desnick RJ (1991): δ-Aminolevulinate dehydratase deficient porphyria: Identification of the molecular lesions in a severely affected homozygote. Am J Hum Genet 49:167-174.
32. Pruszkowska E, Carnrick GR, Slavin W (1983): Blood lead determination with the platform furnace technique. Atomic Spect 4:59-61.
33. Potluri VR, Astrin KH, Wetmur JG, Bishop DF, Desnick RJ (1987): Human delta-aminolevulinate dehydratase: Chromosomal localization to 9q34 by in situ hybridization. Human Genet 76:236-239.
34. Schwartz BS, Lee BK, Stewart W, Sithisarankul P, Strickland PT, Ahn KD, Kelsey KT (1997): δ-Aminolevulinic acid dehydratase genotype modifies four-hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med (in press).
35. Schwartz BS, Lee B-K, Stewart W, Ahn K-D, Springer K, Kelsey K (1995): Associations of δ-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142:738-745.
36. Silbergeld EK, Lamon JM (1980): Role of altered heme synthesis in lead neurotoxicity. J Occup Med 22:680-684.
37. Silbergeld EK, Lamon JM (1982): Effects of altered porphyrin synthesis on brain neurochemistry. Neurobehav Toxicol Teratol 4:635-642.
38. Smith CM, Wang X, Hu H, Kelsey KT (1995): A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253.
39. Sweeney VP, Pathak MA, Asbury AK (1970): Acute intermittent porphyria: Increased ALA-synthetase activity during an acute attack. Brain 93:369-380.
40. Takebayashi T, Omae K, Hosoda K, Satoh T, Hamaguchi T, Sakurai H (1993): Evaluation of δ-aminolaevulinic acid in blood of workers exposed to lead. B J Ind Med 50:49-54.
41. Thunell S, Holmberg L, Lundgren J (1987): Aminolaevulinate dehydratase porphyria in infancy. A clinical and biochemical study. J Clin Chem Clin Biochem 25:5-14.
42. Tomokuni K, Ichiba M, Fujishiro K (1993a): Interrelation between urinary δ-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead. Ind Health 31:51-57.
43. Tomokuni K, Ichiba M, Hirai Y (1993b): HPLC micro-method for determining δ-aminolevulinic acid in plasma. Clin Chem 39:169-170.
44. Wetmur JG, Bishop DF, Cantelmo C, Desnick RJ (1986): Human δ-aminolevulinate dehydratase: Nucleotide sequence of a full-length cDNA clone. Proc Natl Acad Sci USA 83:7703-7707.
45. 2) allele: Implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 49:757-763.
46. Wetmur JG, Lehnert G, Desnick RJ (1991b): The δ-aminolevulinate dehydratase polymorphism: Higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56:109-119.
47. Yeung Laiwah AC, Moore MR, Goldberg A (1987): Pathogenesis of acute porphyria. Quart J Med, New Series 63:377-392.
48. Ziemsen B, Angerer J, Lehnert G, Benkmann HG, Goedde HW (1986): Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 58:245-247.